Enter assignee name

% Expired Patents = 12.5

EPO Patents = 1

Trademarks = 3

Forward Citations = 5

Loading Chart...

17 inventors (with patents filed for the assignee):

Magdalena Alonso-Galicia (4 out of 4 patents)

Steve Wring (3 out of 3 patents)

Thomas Pack (3 out of 4 patents)

4. Julie Rurka (3 out of 3 patents)

5. Melissa Rhodes (3 out of 4 patents)

6. David J Carpenter (3 out of 25 patents)

7. Stéphane De Lombaert (2 out of 13 patents)

8. Daniel R Goldberg (2 out of 53 patents)

9. Kenneth Albert Brameld (1 out of 27 patents)

10. Daniel Patterson (1 out of 2 patents)

11. Shanie Everts (1 out of 1 patent)

12. Roy C Levitt, Jr (1 out of 3 patents)

13. Andrew Scribner (1 out of 12 patents)

14. Eric J Gaukel (1 out of 1 patent)

15. Stephen A Wring (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 11911382 - Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension (2024-02-27),

2. 11759462 - Spirocyclic compounds as tryptophan hydroxylase inhibitors (2023-09-19),

3. 11708365 - Processes for preparing TPH1 inhibitors (2023-07-25),

4. 11607413 - Dosage regime and method for treating pulmonary arterial hypertension (2023-03-21),

5. 11576915 - Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension and daily dosing (2023-02-14),

6. 11413287 - Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension (2022-08-16),

7. 11203597 - Crystalline spirocyclic compound, a dosage form containing, a method for using in treatment of disease, and a method for recrystallizing (2021-12-21),

8. 11091763 - Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors (2021-08-17),

Altavant Sciences is a clinical-stage pharmaceutical company focused on developing innovative therapies for respiratory diseases. The company's pipeline includes potential treatments for cystic fibrosis and primary ciliary dyskinesia. Altavant Sciences is committed to improving the lives of patients with significant unmet medical needs through groundbreaking research and development.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

8 Patents

#46 in Basel

#1,221 in Switzerland

Basel, Switzerland

Altavant Sciences Gmbh